Alpa Laboratories Share Price

Alpa Laboratories Share Price

NSE: ALPA
|
Pharmaceuticals
|
S Cap
₹ 62.71
-₹0.59 (-0.93%)
1D
Last updated 04 Sep, 2026, 15:29 IST

Alpa Laboratories Share Price Today

As of 4 Sep 2026, Alpa Laboratories share price is ₹62.71. The stock opened at ₹64.00, compared to its previous close of ₹63.30. During today's trading session, Alpa Laboratories share price moved in the range of ₹61.50 to ₹64.00, with an average price of ₹62.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹46.10 and a high of ₹99.00. On the performance front, Alpa Laboratories share price has declined by 1.71% over the last six months and is down 34.44% on a year-on-year basis.

₹61.50
0.93% down today
₹64.00
1D LOW
1D HIGH

Alpa Laboratories Returns Calculator

Circuit
L
H
₹50.64
₹75.96
52-week
L
H
₹46.10
₹99.00

About Alpa Laboratories

Alpa Laboratories Share Price
ISIN
INE385I01010
Sector Market Cap
₹ 134.41 Cr

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Alpa Laboratories Financial Highlights

  • Revenue: Alpa Laboratories reported revenue of ₹121.57 crore in FY26 vs ₹135.80 crore in FY25. It showed a decrease of 10.48% on a yearly basis.
  • Operating Profit: Alpa Laboratories reported an operating profit of ₹16.70 crore in FY26 vs ₹25.67 crore in FY25. It showed a decrease of 34.94% on a year-on-year basis.
  • Net Profit: Alpa Laboratories reported a net profit of ₹15.01 crore in FY26 vs ₹19.50 crore in FY25. It showed a decrease of 23.03% on a yearly basis.

Alpa Laboratories Quarterly Result Highlights

  • Alpa Laboratories reported revenue of ₹29.70 crore in Jun 2026, compared with ₹31.24 crore in Mar 2026, representing a decrease of 4.93% on a quarter-on-quarter (QoQ) basis.
  • Alpa Laboratories reported an operating profit of ₹0.98 crore in Jun 2026, compared with ₹3.07 crore in Mar 2026, representing a decrease of 68.08% on a quarter-on-quarter (QoQ) basis.
  • Alpa Laboratories reported a profit of ₹0.98 crore in Jun 2026, compared with ₹1.38 crore in Mar 2026, reflecting a decrease of 28.99% on a QoQ basis.
  • The earnings per share (EPS) of Alpa Laboratories stood at ₹9.34 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
57.19%
FII
0.35%
Other DII
0.07%
Retail and other
42.39%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.35%
Dec 20250.36%
Mar 20260.38%
Jun 20260.35%
Mkt Cap Cr
134.41
P/E
33.10
P/B
0.72
ROE
8.06%
D/E
0.01
ROCE
8.98%
Div. Yield
0.00%
EPS(TTM)
6.69
Turnover
0.44
EV/EBITDA
15.61
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.68%
Quick Ratio
0.00
Curr. Ratio
4.18
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Alpa Laboratorie has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Alpa Laboratorie appears overvalued compared to its peers
Step 1 of 5
Earnings
Very Poor
Alpa Laboratorie revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,833.0037.705.4713.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,426.0083.9114.6415.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,320.0086.8922.2825.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,13,217.0024.654.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.443.2611.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,01,155.0092.7719.0916.77%0.4016.14%97.200.11%0.6713.72
Lupin97,626.3017.594.3523.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma96,859.1046.845.9411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.282.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma93,614.0025.232.479.25%0.1911.76%394.820.25%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Alpa Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹112.45₹108.74₹92.96₹112.27
Other Income₹23.35₹14.89₹9.37₹10.78
Total Revenue₹135.80₹123.63₹102.32₹123.04
Total Expenses₹110.13₹102.95₹86.43₹103.48
Profit Before Tax₹25.67₹20.68₹15.89₹19.56
Tax₹6.16₹3.91₹3.31₹5.47
Profit After Tax₹19.50₹16.78₹12.58₹14.09
EPS - Basic₹9.34₹8.01₹5.88₹6.70
EPS - Diluted₹9.34₹8.01₹5.88₹6.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹25.82₹20.76₹15.68₹19.56
Income before WC changes₹10.10₹11.35₹13.30₹11.60
Change in Assets-₹11.56₹4.23-₹3.82₹8.68
Change in Liabilities₹23.85-₹8.29₹3.02-₹7.23
Change in WC₹12.28-₹4.06-₹0.80₹1.45
Cash flow from Operations₹18.32₹3.65₹8.90₹9.94
Cash flow from Investing-₹12.36-₹13.34₹2.13-₹15.61
Cash flow from Financing-₹5.44₹2.58-₹3.79₹5.44
Total Cash Flow₹0.51-₹7.10₹7.24-₹0.23
Cash (Start of the year)₹3.11₹10.21₹1.58₹1.80
Cash (End of the year)₹3.62₹3.11₹8.81₹1.58

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹30.14₹21.39₹18.14₹17.23
Current Assets₹192.49₹160.98₹149.13₹138.01
Total Assets₹222.63₹182.37₹167.27₹155.24
Current Liabilities₹46.70₹28.07₹29.63₹31.38
Net Current Asset₹145.79₹132.92₹119.50₹106.63
Non-Current Liabilities₹4.49₹2.40₹3.06₹2.12
Equity Capital₹171.43₹151.91₹134.58₹121.73
Total Equity & Liabilities₹222.63₹182.37₹167.27₹155.24

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹112.45₹108.74₹92.96₹112.27
Other Income₹23.31₹14.87₹9.41₹10.79
Total Revenue₹135.76₹123.61₹102.36₹123.06
Total Expenses₹109.92₹102.94₹86.43₹103.48
Profit Before Tax₹25.84₹20.67₹15.93₹19.58
Tax₹6.16₹3.90₹3.31₹5.45
Profit After Tax₹19.68₹16.78₹12.62₹14.13
EPS - Basic₹9.42₹8.01₹5.90₹6.71
EPS - Diluted₹9.42₹8.01₹5.90₹6.71

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹25.99₹20.76₹15.72₹19.58
Income before WC changes₹10.21₹10.90₹14.25₹11.63
Change in Assets-₹11.59₹1.72-₹3.66₹1.09
Change in Liabilities₹23.84-₹5.29₹3.20-₹6.95
Change in WC₹12.25-₹3.57-₹0.46-₹5.85
Cash flow from Operations₹18.39₹3.70₹10.20₹2.20
Cash flow from Investing-₹12.49-₹13.45₹1.17-₹15.61
Cash flow from Financing-₹5.48₹2.26-₹3.48₹5.41
Total Cash Flow₹0.43-₹7.49₹7.89-₹7.99
Cash (Start of the year)₹2.62₹10.14₹2.24₹10.85
Cash (End of the year)₹3.05₹2.66₹10.13₹2.85

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹41.53₹32.65₹29.29₹28.33
Current Assets₹191.45₹159.77₹148.80₹136.81
Total Assets₹232.98₹192.42₹178.09₹165.14
Current Liabilities₹46.69₹28.06₹29.92₹28.80
Net Current Asset₹144.77₹131.72₹118.88₹108.01
Non-Current Liabilities₹4.49₹2.40₹3.06₹4.70
Equity Capital₹181.80₹161.97₹145.11₹131.64
Total Equity & Liabilities₹232.98₹192.42₹178.09₹165.14
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
46.11
Neutral
ATR (14)
2.63
Neutral
STOCH(9,6)
59.51
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
18.67
Bullish
UO(9)
32.65
Neutral
ROC(12)
1.18
Bullish
WillR(14)
-45.19
Neutral
Period
Simple value
Exponential vaue
5D
62.93
62.8
10D
62.38
62.82
20D
63.72
63.65
50D
66.38
65.49
100D
67.62
66.77
Volume trend — traded volume by day
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Alpa Laboratories Share Price
Alpa Laboratories
Pharmaceuticals
Add Stock
Add Another

Alpa Laboratories Share Price FAQs

Alpa Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837